Desoxyfructo-serotonin
Sign in to saveDesoxyfructo-serotonin is a leprostatic agent.
Research
25 papers- Re-evaluation of the uptake of desoxyfructo-serotonin by human platelets, and of its effect on the uptake of serotonin.Research communications in chemical pathology and pharmacology · 1979
- Desoxyfructo-serotonin: in vitro toxicity and mutagenesis.Acta leprologica · 1983
- Desoxyfructo-serotonin: first human metabolite with antileprosy activity.Acta leprologica · 1981
- New method to increase the serotonin level in brain by carotid injection of desoxyfructo-serotonin in mice.Biochemical pharmacology · 1982
- [Desoxyfructo-serotonin: its therapeutic effect in the treatment of leprosy].Acta leprologica · 1989
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 424680486 | ImageFile=Desoxyfructo-serotonin.png | ImageClass = skin-invert-image | ImageSize=200px | IUPACName=1-Deoxy-1-{[2-(5-hydroxy-1H-indol-3-yl)ethyl]amino}-D-fructose | SystematicName=(3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-{[2-(5-hydroxy-1H-indol-3-yl)ethyl]amino}hexan-2-one | OtherNames=Deoxyfructo-serotonin; Desoxyfructosylserotonin; 1-Desoxy-(5-hydroxytryptamino)-D-fructose |Section1= |Section2= |Section3= }}
Desoxyfructo-serotonin is a leprostatic agent.
Excerpted from Wikipedia’s “Desoxyfructo-serotonin” article, available under the CC BY-SA 4.0 licence.